Xenon Pharmaceuticals Other Current Assets (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

41.66 -0.58 (-1.37%) USD | NASDAQ | Jan 23, 13:57

View Other Current Assets (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Assets (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	--
ProMIS Neurosciences, Inc.	Upgrade